Check out which companies are making headlines before the bell:
Time Warner — The media giant reported adjusted quarterly profit of $1.06 per share, 5 cents above estimates. Revenue came in below forecasts, impacted in part by a strong dollar, but Time Warner gave a 2016 earnings outlook that exceeds consensus and also raised its quarterly dividend by 15 percent.
Walt Disney — Disney reported adjusted quarterly profit of $1.63 per share compared to consensus estimates of $1.45. Revenue also beat estimates, thanks in part to the success of the latest "Star Wars" movie. However, shares are under pressure on continued worried about declines in profit at ESPN and other Disney-owned channels.
Consol Energy — The coal producer's stock is higher after the Supreme Court blocked a White House plan to limit carbon emissions from power plants.
Pandora — Cowen cut the online radio service's stock to "market perform" from "outperform," primarily on expectations of falling ad sales.
Hess — Goldman added the oil company to its "conviction buy" list, upgrading it from a "neutral" rating. Goldman said Hess has good liquidity, significant resource expansion opportunities, and is well positioned to benefit if oil prices rebound.
Akamai Technologies — Akamai beat estimates by 10 cents with adjusted quarterly profit of 72 cents per share, with revenue also above forecasts. The distributor of online content was helped by stronger demand for security-related technology, and Akamai also unveiled a $1 billion share buyback program.
Panera Bread — Panera earned an adjusted $1.88 per share, 10 cents above estimates, but the restaurant chain's revenue came in below forecasts. Panera did say that higher prices helped sales increase during the quarter, and expects growth to be sustained this year.
Western Union — The company matched estimates with quarterly profit of 42 cents per share, with revenue slightly below analyst forecasts. However, the money transfer company gave weaker than expected guidance for 2016, hurt by the strong dollar. Western Union did increase its quarterly dividend by a half cent to 16 cents per share.
Johnson & Johnson — An FDA panel recommended approval for a copy of J&J's Remicade arthritis drug. Pfizer holds the license for the drug. Major drug makers have attempted to block the sale of so-called "biosimilars" by taking out new patents on the best-selling originals.
Anheuser-Busch InBev — Anheuser and SABMiller are near a deal to sell the Peroni and Grolsch brands to Japan's Asahi for about $3.5 billion, according to Dow Jones. Anheuser and SABMiller are selling the brands to address regulatory concerns about their planned merger.
Novo Nordisk — The Danish biotechnology company is seeing its stock rebound strongly this morning on possible bargain hunting, after the stock had lost 19 percent over the previous five trading days.
SolarCity — SolarCity reported an adjusted quarterly loss of $2.37 per share, 22 cents smaller than analysts had anticipated, and the solar equipment company also saw revenue beat Street estimates. However, SolarCity fell short of projected installations, and also gave a downbeat forecast for the current quarter.
Questions? Comments? Email us at firstname.lastname@example.org